The Beatrice Hunter Cancer Research Institute logo
  • Dr. Anna Ignaszak, PhD MSc


Associate Professor


University of New Brunswick, Department of Chemistry

Research Interests:

Electrochemical biosensors, point-of-care, medical diagnostics, lab-on-a-chip, electrochemistry, early detection, cancer biomarkers

Research projects that have been initiated in our laboratory at UNB aim to develop an electrochemical analyzer that provides solution to early screening of selected cancer biomarkers (breast, pancreatic, lungs). Currently, these biomarkers are identified by methods that are tedious, time consuming, and often require expensive instruments located only in hospitals.

The proposed cancer biomarker analyzer has similar technical features to the personal glucose meter, which is widely available in stores and has saved or improved the quality of lives of millions of diabetic patients worldwide. The great success of this sensor is largely due to its portable, reliable quantitative results and simple operation in non-clinical settings.

What brought you to your current institution? I was offered tenured professorship in analytical chemistry at UNB and moved to Fredericton from the Friedrich-Schiller Universität in Jena Germany. My first academic appointment in Canada was at the University of British Columbia (Vancouver campus), followed by a research associate position at the National Research Council (NRC, Vancouver).

Hometown: I am originally from Poland, currently living in Fredericton, NB.

Why are you interested in your area of research? I am very interested in biomedical diagnostics and precision electronics. My training is in chemical engineering, I want to use my technical skills in prototyping and designing to create new devices that can help in early screening of cancer biomarkers. Whenever possible, we should use everybody’s expertise to fight against deadly diseases.

Learn More about my research:

Twitter Account: Follow me on Twitter @IgnaszakLab

Involvement with BHCRI to date:

A member of BHCRI since April 2022

Site by: Spectacle Group